AVITA Medical, Inc. (RCEL)
13.21
-0.12
(-0.90%)
USD |
NASDAQ |
Oct 09, 16:00
13.20
-0.01
(-0.08%)
After-Hours: 20:00
AVITA Medical Free Cash Flow : -25.21M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.21M |
| March 31, 2026 | -32.43M |
| December 31, 2025 | -32.88M |
| September 30, 2025 | -36.54M |
| June 30, 2025 | -41.52M |
| March 31, 2025 | -46.03M |
| December 31, 2024 | -57.58M |
| September 30, 2024 | -60.09M |
| June 30, 2024 | -57.67M |
| March 31, 2024 | -51.38M |
| Date | Value |
|---|---|
| December 31, 2023 | -38.66M |
| September 30, 2023 | -30.71M |
| June 30, 2023 | -24.07M |
| March 31, 2023 | -18.51M |
| December 31, 2022 | -18.59M |
| September 30, 2022 | -19.33M |
| June 30, 2022 | -26.86M |
| March 31, 2022 | -29.39M |
| June 30, 2021 | -27.96M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Halozyme Therapeutics, Inc. | 806.22M |
| Iovance Biotherapeutics, Inc. | -296.40M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 10.18B |
| Editas Medicine, Inc. | -120.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.630M |
| Cash from Investing (Quarterly) | 3.947M |
| Cash from Financing (Quarterly) | 0.5013M |
| Free Cash Flow Per Share (Quarterly) | -0.1217 |
| Free Cash Flow to Equity (Quarterly) | -4.103M |
| Free Cash Flow to Firm (Quarterly) | -2.272M |
| Free Cash Flow Yield | -6.36% |